ALVAC-CEA vaccine is a cancer vaccine containing a canary pox virus (ALVAC) combined with the carcinoembryonic antigen (CEA) human gene.
A phase I trial in 118 patients showed safety in humans.
References
External links ALVAC-CEA vaccine entry in the public domain NCI Dictionary of Cancer Terms